FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula (I) or a tautomeric form thereof, a stereoisomer, a solvate or a pharmaceutically acceptable salt thereof, where in said formula ---- is a single bond or a double bond; X is selected from -O- or -N-; n equals 0–1; R 1 is C1-C8-alkyl; R2 and R3 are selected independently from hydrogen, halogen, hydroxy, C1-C8-halogenalkyl, independently substituted with up to three halogen atoms selected from fluorine, chlorine, bromine or iodine, C1-C8-alkoxy, C1-C8-haloalkoxy; R4 is selected from C1-C8-alkyl, C3-C8-cycloalkyl, C3-C8-cycloalkylalkyl, C6-C18-aryl, C2-C18-heteroaryl or C1-C8-haloalkyl, where alkyl, cycloalkyl, cycloalkylalkyl, aryl and heteroaryl independently are unsubstituted or substituted by up to three substituents independently selected from halogen, C1-C8-alkyl and cyano, and where heteroaryl contains up to three heteroatoms selected from O, N or S atoms; Z is selected from hydrogen, -CH2OR5, -COOR5, -CONR5R6, -NHCOOR5 or -NHCOR5, where R5 and R6 are independently selected from hydrogen, C6-C18-aryl or C1-C8-alkyl; where R5 and R6 are optionally substituted with one or more substitutes selected from hydroxy, oxo (=O) or C1-C8-alkyl. Invention also relates to a pharmaceutical composition based on said compounds.
I.
EFFECT: novel compounds and a pharmaceutical composition based thereon, which can be used in medicine for treating cancer.
17 cl, 1 tbl, 46 ex
Title | Year | Author | Number |
---|---|---|---|
TRICYCLIC CONDENSED DERIVATIVES OF PYRIDIN-2-ONE AND USE THEREOF AS BRD4 INHIBITORS | 2016 |
|
RU2734959C2 |
BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
NOVEL COMPOUNDS OF SUBSTITUTED N-(3-FLUOROPROPYL)PYRROLIDINE, METHODS FOR PRODUCTION THEREOF AND THERAPEUTIC APPLICATION THEREOF | 2017 |
|
RU2742278C2 |
AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
NEW SUBSTITUTED 8-HETEROARYLXANTINES AND BASED PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2357969C2 |
PROLYL HYDROXYLASE INHIBITORS | 2010 |
|
RU2518071C2 |
5-HT RECEPTOR MODULATORS AND METHODS FOR USING THEM | 2010 |
|
RU2542103C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS | 2009 |
|
RU2532161C2 |
IMIDAZOTRIAZINONE COMPOUNDS | 2011 |
|
RU2603140C2 |
Authors
Dates
2020-05-15—Published
2016-03-30—Filed